Seminars in Pediatric Neurology
Volume 13, Issue 1 , Pages 21-26 , March 2006

The Genetic and Molecular Pathogenesis of NF1 and NF2

  • Kaleb H. Yohay, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Kaleb H. Yohay, MD, Division of Child Neurology and Pediatrics, Johns Hopkins University, Jefferson 123, 600 North Wolfe Street, Baltimore, MD 21287-1000.

References 

  1. Lazaro C , Ravella A , Gaona A , et al.   Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father . N Engl J Med . 1994;331:1403–1407
  2. Littler M , Morton NE . Segregation analysis of peripheral neurofibromatosis (NF1) . J Med Genet . 1990;27:307–310
  3. Evans DG , Huson SM , Donnai D , et al.   A genetic study of type 2 neurofibromatosis in the United Kingdom . I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity J Med Genet . 1992;29:841–846
  4. Riccardi VM , Lewis RA . Penetrance of von Recklinghausen neurofibromatosis (a distinction between predecessors and descendants) . Am J Hum Genet . 1988;42:284–289
  5. Cnossen MH , van der Est MN , Breuning MH , et al.   Deletions spanning the neurofibromatosis type 1 gene (implications for genotype-phenotype correlations in neurofibromatosis type 1?) . Hum Mutat . 1997;9:458–464
  6. Kayes LM , Burke W , Riccardi VM , et al.   Deletions spanning the neurofibromatosis 1 gene (identification and phenotype of five patients) . Am J Hum Genet . 1994;54:424–436
  7. Ruttledge MH , Andermann AA , Phelan CM , et al.   Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease . Am J Hum Genet . 1996;59:331–342
  8. Baser ME , Kuramoto L , Joe H , et al.   Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2 (a population-based study) . Am J Hum Genet . 2004;75:231–239
  9. Evans DG , Huson SM , Donnai D , et al.   A genetic study of type 2 neurofibromatosis in the United Kingdom . II. Guidelines for genetic counselling J Med Genet . 1992;29:847–852
  10. Basu TN , Gutmann DH , Fletcher JA , et al.   Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients . Nature . 1992;356:713–715
  11. Gijtenbeek JM , Gabreels-Festen AA , Lammens M , et al.   Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2 . Neurology . 2001;56:1766–1768
  12. Wallace MR , Marchuk DA , Andersen LB , et al.   Type 1 neurofibromatosis gene (identification of a large transcript disrupted in three NF1 patients) . Science . 1990;249:181–186
  13. DeClue JE , Papageorge AG , Fletcher JA , et al.   Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis . Cell . 1992;69:265–273
  14. Li Y , Bollag G , Clark R , et al.   Somatic mutations in the neurofibromatosis 1 gene in human tumors . Cell . 1992;69:275–281
  15. Heim RA , Silverman LM , Farber RA , et al.   Screening for truncated NF1 proteins . Nat Genet . 1994;8:218–219
  16. Viskochil D , Buchberg AM , Xu G , et al.   Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus . Cell . 1990;62:187–192
  17. Xu GF , O’Connell P , Viskochil D , et al.   The neurofibromatosis type 1 gene encodes a protein related to GAP . Cell . 1990;62:599–608
  18. Shen MH , Harper PS , Upadhyaya M . Molecular genetics of neurofibromatosis type 1 (NF1) . J Med Genet . 1996;33:2–17
  19. Cawthon RM , Andersen LB , Buchberg AM , et al.   cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene . Genomics . 1991;9:446–460
  20. Cawthon RM , O’Connell P , Buchberg AM , et al.   Identification and characterization of transcripts from the neurofibromatosis 1 region (the sequence and genomic structure of EVI2 and mapping of other transcripts) . Genomics . 1990;7:555–565
  21. Viskochil D , Cawthon R , O’Connell P , et al.   The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene . Mol Cell Biol . 1991;11:906–912
  22. Gutmann DH , Wood DL , Collins FS . Identification of the neurofibromatosis type 1 gene product . Proc Natl Acad Sci U S A . 1991;88:9658–9662
  23. DeClue JE , Cohen BD , Lowy DR . Identification and characterization of the neurofibromatosis type 1 protein product . Proc Natl Acad Sci U S A . 1991;88:9914–9918
  24. Bollag G , McCormick F , Clark R . Characterization of full-length neurofibromin (tubulin inhibits Ras GAP activity) . EMBO J . 1993;12:1923–1927
  25. Gutmann DH , Collins FS . The neurofibromatosis type 1 gene and its protein product, neurofibromin . Neuron . 1993;10:335–343
  26. Daston MM , Scrable H , Nordlund M , et al.   The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes . Neuron . 1992;8:415–428
  27. Gregory PE , Gutmann DH , Mitchell A , et al.   Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules . Somat Cell Mol Genet . 1993;19:265–274
  28. Suzuki Y , Suzuki H , Kayama T , et al.   Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain . Biochem Biophys Res Commun . 1991;181:955–961
  29. Nishi T , Lee PS , Oka K , et al.   Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation . Oncogene . 1991;6:1555–1559
  30. Malhotra R , Ratner N . Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin . J Invest Dermatol . 1994;102:812–818
  31. Heim RA , Silverman LM , Farber RA , et al.   Screening for truncated NF1 proteins . Nat Genet . 1994;8:218–219
  32. Friedman JM . Epidemiology of neurofibromatosis type 1 . Am J Med Genet . 1999;89:1–6
  33. Riccardi VM . Molecular biology of the neurofibromatoses . Semin Dermatol . 1993;12:266–273
  34. Easton DF , Ponder MA , Huson SM , et al.   An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1) (evidence for modifying genes) . Am J Hum Genet . 1993;53:305–313
  35. Heim RA , Kam-Morgan LN , Binnie CG , et al.   Distribution of 13 truncating mutations in the neurofibromatosis 1 gene . Hum Mol Genet . 1995;4:975–981
  36. Park VM , Pivnick EK . Neurofibromatosis type 1 (NF1) (a protein truncation assay yielding identification of mutations in 73% of patients) . J Med Genet . 1998;35:813–820
  37. Messiaen LM , Callens T , Mortier G , et al.   Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects . Hum Mutat . 2000;15:541–555
  38. Frahm S , Mautner VF , Brems H , et al.   Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients . Neurobiol Dis . 2004;16:85–91
  39. Kai S , Sumita H , Fujioka K , et al.   Loss of heterozygosity of NF1 gene in juvenile chronic myelogenous leukemia with neurofibromatosis type 1 . Int J Hematol . 1998;68:53–60
  40. Gutmann DH , Cole JL , Stone WJ , et al.   Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I . Genes Chromosomes Cancer . 1994;10:55–58
  41. Gutmann DH , Donahoe J , Brown T , et al.   Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas . Neuropathol Appl Neurobiol . 2000;26:361–367
  42. Gutmann DH , James CD , Poyhonen M , et al.   Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1 . Neurology . 2003;61:1397–1400
  43. Colman SD , Williams CA , Wallace MR . Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene . Nat Genet . 1995;11:90–92
  44. Sawada S , Florell S , Purandare SM , et al.   Identification of NF1 mutations in both alleles of a dermal neurofibroma . Nat Genet . 1996;14:110–112
  45. Serra E , Puig S , Otero D , et al.   Confirmation of a double-hit model for the NF1 gene in benign neurofibromas . Am J Hum Genet . 1997;61:512–519
  46. Kluwe L , Friedrich R , Mautner VF . Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma . Genes Chromosomes Cancer . 1999;24:283–285
  47. Guran S , Safali M . A case of neurofibromatosis and breast cancer (loss of heterozygosity of NF1 in breast cancer) . Cancer Genet Cytogenet . 2005;156:86–88
  48. Cacev T , Radosevic S , Spaventi R , et al.   NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer . Gut . 2005;54:1129–1135
  49. Martinsson T , Sjoberg RM , Hedborg F , et al.   Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma . Cancer Genet Cytogenet . 1997;95:183–189
  50. Ingram DA , Yang FC , Travers JB , et al.   Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo . J Exp Med . 2000;191:181–188
  51. Rizvi TA , Akunuru S , de Court  , et al.   Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor . Brain Res . 1999;816:111–123
  52. Nordlund ML , Rizvi TA , Brannan CI , et al.   Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains . J Neuropathol Exp Neurol . 1995;54:588–600
  53. Gutmann DH , Loehr A , Zhang Y , et al.   Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation . Oncogene . 1999;18:4450–4459
  54. Bajenaru ML , Donahoe J , Corral T , et al.   Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes . Glia . 2001;33:314–323
  55. Gutmann DH , Wu YL , Hedrick NM , et al.   Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes . Hum Mol Genet . 2001;10:3009–3016
  56. Bos JL . ras oncogenes in human cancer (a review) . Cancer Res . 1989;49:4682–4689
  57. Bollag G , McCormick F . Differential regulation of rasGAP and neurofibromatosis gene product activities . Nature . 1991;351:576–579
  58. Bollag G , Clapp DW , Shih S , et al.   Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells . Nat Genet . 1996;12:144–148
  59. Feldkamp MM , Lau N , Provias JP , et al.   Acute presentation of a neurogenic sarcoma in a patient with neurofibromatosis type 1: a pathological and molecular explanation. Case report . J Neurosurg . 1996;84:867–873
  60. The I , Hannigan GE , Cowley GS , et al.   Rescue of a Drosophila NF1 mutant phenotype by protein kinase A . Science . 1997;276:791–794
  61. Johnson MR , Look AT , DeClue JE , et al.   Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP . Ras. Proc Natl Acad Sci U S A . 1993;90:5539–5543
  62. Zang KD . Cytological and cytogenetical studies on human meningioma . Cancer Genet Cytogenet . 1982;6:249–274
  63. Rouleau GA , Wertelecki W , Haines JL , et al.   Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22 . Nature . 1987;329:246–248
  64. Rouleau GA , Merel P , Lutchman M , et al.   Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 . Nature . 1993;363:515–521
  65. Trofatter JA , MacCollin MM , Rutter JL , et al.   A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor . Cell . 1993;72:791–800
  66. Kluwe L , Friedrich RE , Hagel C , et al.   Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors . J Invest Dermatol . 2000;114:1017–1021
  67. Hung G , Faudoa R , Baser ME , et al.   Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas . Cancer Genet Cytogenet . 2000;118:167–168
  68. Lamszus K , Vahldiek F , Mautner VF , et al.   Allelic losses in neurofibromatosis 2-associated meningiomas . J Neuropathol Exp Neurol . 2000;59:504–512
  69. Lasota J , Wozniak A , Kopczynski J , et al.   Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs) (a study on 50 cases) . Lab Invest . 2005;85:237–247
  70. Ueki K , Wen-Bin C , Narita Y , et al.   Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas . Cancer Res . 1999;59:5995–5998
  71. Pylkkanen L , Sainio M , Ollikainen T , et al.   Concurrent LOH at multiple loci in human malignant mesothelioma with preferential loss of NF2 gene region . Oncol Rep . 2002;9:955–959
  72. Lamszus K , Lachenmayer L , Heinemann U , et al.   Molecular genetic alterations on chromosomes 11 and 22 in ependymomas . Int J Cancer . 2001;91:803–808
  73. Lomas J , Bello MJ , Arjona D , et al.   Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas . Genes Chromosomes Cancer . 2005;42:314–319
  74. Kino T , Takeshima H , Nakao M , et al.   Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma . Genes Cells . 2001;6:441–454
  75. Gonzalez-Gomez P , Bello MJ , Alonso ME , et al.   CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas . Clin Cancer Res . 2003;9:5601–5606
  76. Parry DM , Eldridge R , Kaiser-Kupfer MI , et al.   Neurofibromatosis 2 (NF2) (clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity) . Am J Med Genet . 1994;52:450–461
  77. Zhao Y , Kumar RA , Baser ME , et al.   Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2) . Genet Epidemiol . 2002;23:245–259
  78. Baser ME , Ragge NK , Riccardi VM , et al.   Phenotypic variability in monozygotic twins with neurofibromatosis 2 . Am J Med Genet . 1996;64:563–567
  79. Parry DM , MacCollin MM , Kaiser-Kupfer MI , et al.   Germ-line mutations in the neurofibromatosis 2 gene (correlations with disease severity and retinal abnormalities) . Am J Hum Genet . 1996;59:529–539
  80. Baser ME , Kuramoto L , Woods R , et al.   The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2 . J Med Genet . 2005;42:540–546
  81. Maccollin M , Ramesh V , Jacoby LB , et al.   Mutational analysis of patients with neurofibromatosis 2 . Am J Hum Genet . 1994;55:314–320
  82. Tsukita S , Yonemura S , Tsukita S . ERM proteins (head-to-tail regulation of actin-plasma membrane interaction) . Trends Biochem Sci . 1997;22:53–58
  83. Pearson MA , Reczek D , Bretscher A , et al.   Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain . Cell . 2000;101:259–270
  84. Kang BS , Cooper DR , Devedjiev Y , et al.   The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product . Acta Crystallogr D Biol Crystallogr . 2002;58:381–391
  85. Shimizu T , Seto A , Maita N , et al.   Structural basis for neurofibromatosis type 2 . Crystal structure of the merlin FERM domain. J Biol Chem . 2002;277:10332–10336
  86. Sherman L , Xu HM , Geist RT , et al.   Interdomain binding mediates tumor growth suppression by the NF2 gene product . Oncogene . 1997;15:2505–2509
  87. Gutmann DH , Haipek CA , Hoang LK . Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations . J Neurosci Res . 1999;58:706–716
  88. Sherman L , Xu HM , Geist RT , et al.   Interdomain binding mediates tumor growth suppression by the NF2 gene product . Oncogene . 1997;15:2505–2509
  89. Gutmann DH , Geist RT , Xu H , et al.   Defects in neurofibromatosis 2 protein function can arise at multiple levels . Hum Mol Genet . 1998;7:335–345
  90. McClatchey AI , Saotome I , Ramesh V , et al.   The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation . Genes Dev . 1997;11:1253–1265
  91. McClatchey AI , Saotome I , Mercer K , et al.   Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors . Genes Dev . 1998;12:1121–1133
  92. Giovannini M , Robanus-Maandag E , Niwa-Kawakita M , et al.   Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein . Genes Dev . 1999;13:978–986
  93. Kalamarides M , Niwa-Kawakita M , Leblois H , et al.   Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse . Genes Dev . 2002;16:1060–1065
  94. Schulze KM , Hanemann CO , Muller HW , et al.   Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis . Hum Mol Genet . 2002;11:69–76
  95. Fraenzer JT , Pan H , Minimo L , et al.   Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation . Int J Oncol . 2003;23:1493–1500
  96. Morrison H , Sherman LS , Legg J , et al.   The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44 . Genes Dev . 2001;15:968–980
  97. Ikeda K , Saeki Y , Gonzalez-Agosti C , et al.   Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer . J Neurosurg . 1999;91:85–92
  98. Tikoo A , Varga M , Ramesh V , et al.   An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin) . J Biol Chem . 1994;269:23387–23390
  99. Xiao GH , Chernoff J , Testa JR . NF2 (the wizardry of merlin) . Genes Chromosomes Cancer . 2003;38:389–399
  100. Kissil JL , Wilker EW , Johnson KC , et al.   Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1 . Mol Cell . 2003;12:841–849
  101. Rong R , Tang X , Gutmann DH , et al.   Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L . Proc Natl Acad Sci U S A . 2004;101:18200–18205
  102. Ryu CH , Kim SW , Lee KH , et al.   The merlin tumor suppressor interacts with Ral guanine nucleotide dissociation stimulator and inhibits its activity . Oncogene . 2005;24:5355–5364

PII: S1071-9091(06)00011-8

doi: 10.1016/j.spen.2006.01.007

Seminars in Pediatric Neurology
Volume 13, Issue 1 , Pages 21-26 , March 2006

Article Tools

* Image Usage & Resolution